First Trust Advisors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BBA
CS
TCM
First Trust Advisors's BLUE Position: Q1 2022 in Review
First Trust Advisors sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 260,241 shares — an estimated $52M sold.
First Trust Advisors first reported a position in BLUE in Q3 2015 and held it in 20 quarters. The position peaked at $120M in Q1 2019. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.
- First Trust Advisors reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
- First Trust Advisors sold 260,241 bluebird bio shares in Q1 2022, an estimated $52M.
- First Trust Advisors first reported a position in bluebird bio in Q3 2015 and held it in 20 quarters.
- First Trust Advisors's bluebird bio position peaked at $120M in Q1 2019.
- 174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.
Based on First Trust Advisors's 13F filing for Q1 2022, filed 13 May 2022.